Opportunity Radar

← Back to search

Grant

DoW Breast Cancer, Clinical Research Extension Award

View on Grants.gov ↗ Sign in to save

Type
Grant
Notice type
G
Agency
Defense Health Agency Contracting Activity - DHACA
Sub-agency
DOD-AMRAA
Solicitation #
HT942526BCRPCREA2
Posted
Sep 3, 2026
Response due
Nov 18, 2026
Archive date
Dec 18, 2026
CFDA / Assistance listing
12.420
Total program funding
$8,400,000
Contact
help@eBRAP.org
Source
Grants.gov

Description

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.Distinctive Features:• The research team must include two or more breast cancer consumer advocates.• This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Similar open opportunities